The beneficial effects of beta-blocker in patients with myocardial infarction: What are the underlying mechanisms?

Int J Cardiol. 2024 Jan 15:395:131544. doi: 10.1016/j.ijcard.2023.131544. Epub 2023 Oct 20.

Authors

Yuanyuan Li¹, Shanshan Yao², Xiaoyang Chen³

Affiliations

¹ Department of Cardiology, Longhui County People's Hospital, Longhui 422200, Shaoyang, China.
² Department of Geriatric Medicine, The First People's Hospital of Nanning, Nanning 530022, Guangxi, China.
³ Department of Cardiology, The First People's Hospital of Nanning, Nanning 530022, Guangxi, China. Electronic address: nngxxiaoyangchen@163.com.

PMID: 37866791
DOI: 10.1016/j.ijcard.2023.131544

No abstract available

Keywords: Myocardial infarction; Sympathetic over-activation; beta-blocker.

Publication types

Letter

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Humans
Myocardial Infarction* / drug therapy

Substances

Adrenergic beta-Antagonists